ICPT Annual CFO
-$26.78 M
+$14.29 M+34.79%
31 December 2022
Summary:
As of February 5, 2025, ICPT annual cash flow from operations is -$26.78 million, with the most recent change of +$14.29 million (+34.79%) on December 31, 2022. During the last 3 years, it has risen by +$209.83 million (+88.68%).ICPT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Quarterly CFO
$16.69 M
+$39.99 M+171.61%
30 September 2023
Summary:
As of February 5, 2025, ICPT quarterly cash flow from operations is $16.69 million, with the most recent change of +$39.99 million (+171.61%) on September 30, 2023. Over the past year, it has increased by +$33.27 million (+200.59%).ICPT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT TTM CFO
-$63.02 M
+$33.27 M+34.55%
30 September 2023
Summary:
As of February 5, 2025, ICPT TTM cash flow from operations is -$63.02 million, with the most recent change of +$33.27 million (+34.55%) on September 30, 2023. Over the past year, it has dropped by -$46.22 million (-275.14%).ICPT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.8% | +200.6% | -275.1% |
| 3 y3 years | +88.7% | +141.2% | +70.6% |
| 5 y5 years | +89.9% | +132.3% | +73.4% |
ICPT Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -1127.7% | at high | -1980.6% |
Intercept Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $16.69 M(-171.6%) | -$63.02 M(-34.6%) |
| June 2023 | - | -$23.30 M(-54.8%) | -$96.29 M(+65.3%) |
| Mar 2023 | - | -$51.60 M(+973.6%) | -$58.25 M(+117.5%) |
| Dec 2022 | -$26.78 M(-34.8%) | -$4.81 M(-71.0%) | -$26.78 M(+59.4%) |
| Sept 2022 | - | -$16.59 M(-212.6%) | -$16.80 M(-601.3%) |
| June 2022 | - | $14.74 M(-173.2%) | $3.35 M(-151.2%) |
| Mar 2022 | - | -$20.12 M(-488.9%) | -$6.54 M(-84.1%) |
| Dec 2021 | -$41.07 M(-76.1%) | $5.17 M(+45.3%) | -$41.07 M(-35.9%) |
| Sept 2021 | - | $3.56 M(-26.5%) | -$64.05 M(-40.7%) |
| June 2021 | - | $4.85 M(-108.9%) | -$108.09 M(-15.4%) |
| Mar 2021 | - | -$54.65 M(+206.8%) | -$127.78 M(-25.6%) |
| Dec 2020 | -$171.86 M(-27.4%) | -$17.81 M(-56.0%) | -$171.86 M(-19.9%) |
| Sept 2020 | - | -$40.48 M(+172.7%) | -$214.53 M(-2.8%) |
| June 2020 | - | -$14.84 M(-85.0%) | -$220.81 M(-12.3%) |
| Mar 2020 | - | -$98.73 M(+63.2%) | -$251.92 M(+6.5%) |
| Dec 2019 | -$236.61 M(-1.7%) | -$60.48 M(+29.4%) | -$236.61 M(+3.4%) |
| Sept 2019 | - | -$46.76 M(+1.8%) | -$228.94 M(-2.1%) |
| June 2019 | - | -$45.95 M(-44.9%) | -$233.77 M(-0.6%) |
| Mar 2019 | - | -$83.42 M(+58.0%) | -$235.27 M(-2.3%) |
| Dec 2018 | -$240.71 M(-9.3%) | -$52.81 M(+2.4%) | -$240.71 M(-8.9%) |
| Sept 2018 | - | -$51.58 M(+8.7%) | -$264.36 M(-1.7%) |
| June 2018 | - | -$47.45 M(-46.6%) | -$268.92 M(-2.8%) |
| Mar 2018 | - | -$88.87 M(+16.2%) | -$276.77 M(+4.3%) |
| Dec 2017 | -$265.40 M | -$76.46 M(+36.2%) | -$265.40 M(-4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$56.14 M(+1.5%) | -$278.40 M(-16.7%) |
| June 2017 | - | -$55.30 M(-28.6%) | -$334.37 M(-4.5%) |
| Mar 2017 | - | -$77.50 M(-13.4%) | -$350.08 M(+2.2%) |
| Dec 2016 | -$342.44 M(+110.2%) | -$89.46 M(-20.2%) | -$342.44 M(+7.5%) |
| Sept 2016 | - | -$112.10 M(+57.8%) | -$318.67 M(+32.7%) |
| June 2016 | - | -$71.02 M(+1.7%) | -$240.18 M(+18.2%) |
| Mar 2016 | - | -$69.86 M(+6.3%) | -$203.17 M(+24.7%) |
| Dec 2015 | -$162.90 M(+85.7%) | -$65.69 M(+95.4%) | -$162.90 M(+25.9%) |
| Sept 2015 | - | -$33.62 M(-1.1%) | -$129.36 M(+8.2%) |
| June 2015 | - | -$34.00 M(+14.9%) | -$119.60 M(+13.9%) |
| Mar 2015 | - | -$29.59 M(-7.9%) | -$105.01 M(+19.7%) |
| Dec 2014 | -$87.74 M(+213.3%) | -$32.14 M(+34.7%) | -$87.74 M(+32.9%) |
| Sept 2014 | - | -$23.87 M(+23.0%) | -$66.02 M(+35.9%) |
| June 2014 | - | -$19.41 M(+57.6%) | -$48.59 M(+40.1%) |
| Mar 2014 | - | -$12.32 M(+18.2%) | -$34.69 M(+23.9%) |
| Dec 2013 | -$28.01 M(+77.8%) | -$10.42 M(+61.9%) | -$28.01 M(+28.0%) |
| Sept 2013 | - | -$6.44 M(+16.9%) | -$21.87 M(+14.4%) |
| June 2013 | - | -$5.51 M(-2.3%) | -$19.13 M(+9.3%) |
| Mar 2013 | - | -$5.64 M(+31.3%) | -$17.49 M(+11.1%) |
| Dec 2012 | -$15.75 M(-704.4%) | -$4.29 M(+16.4%) | -$15.75 M(+37.5%) |
| Sept 2012 | - | -$3.69 M(-4.8%) | -$11.46 M(+47.5%) |
| June 2012 | - | -$3.88 M(-0.5%) | -$7.77 M(+99.5%) |
| Mar 2012 | - | -$3.89 M | -$3.89 M |
| Dec 2011 | $2.61 M(-119.1%) | - | - |
| Dec 2010 | -$13.66 M | - | - |
FAQ
- What is Intercept Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals annual CFO year-on-year change?
- What is Intercept Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals quarterly CFO year-on-year change?
- What is Intercept Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals TTM CFO year-on-year change?
What is Intercept Pharmaceuticals annual cash flow from operations?
The current annual CFO of ICPT is -$26.78 M
What is the all time high annual CFO for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high annual cash flow from operations is $2.61 M
What is Intercept Pharmaceuticals annual CFO year-on-year change?
Over the past year, ICPT annual cash flow from operations has changed by +$14.29 M (+34.79%)
What is Intercept Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ICPT is $16.69 M
What is the all time high quarterly CFO for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high quarterly cash flow from operations is $16.69 M
What is Intercept Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ICPT quarterly cash flow from operations has changed by +$33.27 M (+200.59%)
What is Intercept Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ICPT is -$63.02 M
What is the all time high TTM CFO for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high TTM cash flow from operations is $3.35 M
What is Intercept Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ICPT TTM cash flow from operations has changed by -$46.22 M (-275.14%)